	Molecular profiling of apoptotic, inflammatory, and angiogenic markers in prostate cancer: Focus on p53, IL-6, IL-8, Bax/Bcl-2 ratio, and VEGF. Wiad Lek Al-Khafaji MH, Hameed WM, Shalla DM, Al-Salihi KA. PMID: 42748310 [PubMed - indexed for MEDLINE]
	Renal-clearable fluorescent probe for early detection of pancreatic cancer in living murine models. Sci Adv Huang M, Zhou Z, Zhang T, Xia X, Chen W, Wang E, Wang F, Ren J. PMID: 42748261 [PubMed - indexed for MEDLINE]
	Castration-resistant prostate cancer as an adaptive tumor ecosystem: coupling tumor evolution with microenvironmental reprogramming. Cancer Metastasis Rev Wang S, Xu X, Xu M, Wei Y, Qiao Y, Song X, Xie C, Zhou C, Yuan F. PMID: 42747576 [PubMed - indexed for MEDLINE]
	Integrated analysis of VEGFA rs833061 (-â€‰460Tâ€‰>â€‰C) promoter polymorphism and serum YKL-40 levels in bladder cancer: evidence of a genotype-phenotype association. Mol Biol Rep Kaushik R, Pawar D, Sharma A, Siwach K, Rohilla G, Narwal S, Khatri N, Arora A, Vashist M. PMID: 42747566 [PubMed - indexed for MEDLINE]
	Survival benchmarking of talazoparib plus enzalutamide in homologous recombination repair-deficient metastatic castration-resistant prostate cancer: a reconstructed individual patient data analysis. Jpn J Clin Oncol Tanaka H, Fukushima H, Tsukahara S, Shiota M, Yoshida S, Fujii Y. PMID: 42747074 [PubMed - as supplied by publisher]
	Assessing the Level of Prostate Cancer Care in a Low-Resource Setting: Disease Pattern, Current Situation of Care, and the Need for Reform-A Retrospective Observational Study From East Oncology Centre, Sudan. Adv Urol Alzubier MAA, Eltahir EA, Allah HMAA, Abubaker MM, Khalid SIO, Abdol AAIE, Daood MAA. PMID: 42746128 [PubMed]
	Lipid metabolic reprogramming in clear cell renal cell carcinoma: focus on high-density lipoprotein-related pathways. Oncol Rev Wu L, Xue H, Wu Y, Shen N, Yang Z, Gao L, Ma W, Wang C. PMID: 42745992 [PubMed]
	Long-term patient-reported outcomes and toxicity following salvage radiotherapy for biochemical recurrence after radical prostatectomy. Cancer Lynch C, Arshad M, Rajeev-Kumar G, Che Y, Skolarus TA, Modi PK, Liauw SL. PMID: 42745507 [PubMed - indexed for MEDLINE]
	Real-World Comparison of Dual Checkpoint Blockade and Immunotherapy Plus TKIs in Metastatic RCC. Cancer Med Ohba K, Oki M, Matsuda T, Miyata H, Kikuchi H, Inoue T, Shin T, Sekine Y, Narita S, Naito S, Tsuchiya N, Naito H, Sugimoto M, Numakura K, Kobayashi S, Ueda K, Igawa T, Mitsunari K, Matsuo T, Imamura R. PMID: 42745451 [PubMed - indexed for MEDLINE]
	Diagnostic performance of AI-powered prostate MRI against biopsy ground truth: quasi-continuous risk scoring versus fixed PI-RADS thresholds. Cancer Imaging Bayerl N, Appel J, Schmidt M, Cavallaro A, Grimm R, von Busch H, Wullich B, Hartmann A, Schlicht M, Uder M, May MS, Ellmann S. PMID: 42745323 [PubMed - indexed for MEDLINE]
	Machine learning and multi-omics clustering to map cellular rewiring and immune evasion in ccRCC. Hum Genomics Wang Z, Wang Y, Zhang J, Zhang Y, Xv S, Zhang L, Wang F, Xin D. PMID: 42745293 [PubMed - indexed for MEDLINE]
	Implementation of Systematic Fourth-Arm Traction and Articulating-Needle Drivers in Senhance Robotic Radical Prostatectomy: Initial Experience. Int J Urol Sekiguchi Z, Sasaki M, Matsumura K, Sato Y, Tomokiyo S, Nakazawa R, Kikuchi E. PMID: 42744745 [PubMed - indexed for MEDLINE]
	The Value of Bayesian Statistics in Prostate Cancer Research: A Clinician-Oriented Review. Clin Genitourin Cancer Yajima S, Yoshida S, Arita Y, Sato H, Hirakawa A, Masuda H, Fujii Y. PMID: 42744731 [PubMed - as supplied by publisher]
	Risk-dependent Benefit of Adjuvant Pembrolizumab in High-risk Clear Cell Renal Cell Carcinoma: A Multi-institutional Study. Eur Urol Oncol Shapiro DD, Roadman DF, Master VA, Peyton CC, McIntosh AG, Manley BJ, Spiess PE, Lotan P, Patil D, Dehghanmanshadi A, Amason R, Bouvette MJ, Blittschau B, Yim KH, Abreu N, Jayakumar V, Allen GO, Sexton WJ, Abel EJ. PMID: 42744717 [PubMed - as supplied by publisher]
	Radiation Therapy for Bladder Cancer: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol Ballas LK, Solanki AA, Baumann BC, Dirix P, Hassanzadeh C, Zaorsky NG, Apolo AB, Choudhury A, Chung PW, Holzbeierlein JM, Joshi M, Kim MM, Lee CT, Moroney W, Ritch CR, Saeed H, Upadhyay R, van der Heijden AG, Bradfield L, Helms AR, Efstathiou JA. PMID: 42744092 [PubMed - as supplied by publisher]
	Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer. JMIR Cancer Isler B, Bayraktar AM. PMID: 42743405 [PubMed - in process]
	Authors' Reply: Urological Content Accuracy as an Unmeasured Dimension in Generative AI Chatbot Communication About Sexual Health After Prostate Cancer. JMIR Cancer Christiansen M, Eriksson H, Fagerström L. PMID: 42743403 [PubMed - in process]
	Effect of demographic characteristics on the outcome of prostate cancer salvage radiotherapy: Analysis from a randomized controlled trial. Cancer Lawal IO, Jani AB, Goyal S, Abiodun-Ojo O, Dhere V, Bell S, Patel P, Hershatter B, Chaudhary K, Mushtaq A, Shelton J, Hanasoge S, Sebastian N, Patel SA, Halkar R, Master VA, Carlos RC, Schuster DM. PMID: 42743317 [PubMed - indexed for MEDLINE]
	Recent studies explore the evolving use of radiation in patients with solid tumors: Radiotherapy may benefit select patients with kidney cancer, but more trials are still needed to determine its role in relation to standard treatments. Cancer Lawrence L. PMID: 42743134 [PubMed - in process]
	Commentary on "PSA density for clinically significant prostate cancer detection: a retrospective cohort study on the influence of age and prostate volume". World J Urol Khan T, Ahmad R, Anwar R. PMID: 42742766 [PubMed - in process]

Articles 1 - 20 / 181482

Page 1 of 9075



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy